Support of HUVEC proliferation by pro-angiogenic intermediate CD163 + monocytes/macrophages: A co-culture experiment

Clinical Hemorheology and Microcirculation

Volumn 49, Issue 1-4, 2011, Pages 423-430

  Mayer, A ^a   Hiebl, B ^a,b   Lendlein, A ^a   Jung, F ^a  

^a Institute of Polymer Research   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN 165;

ANGIOGENESIS; CELL ADHESION; CELL DENSITY; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; COCULTURE; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MONOCYTE; PHENOTYPE; PILOT STUDY; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL COMMUNICATION; CELL DIVISION; CELLS, CULTURED; COCULTURE TECHNIQUES; GLASS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; MONOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; POLYSTYRENES; RECEPTORS, CELL SURFACE; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84856902316     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2011-1492     Document Type: Conference Paper

References (35)

1. A. Akeson, A. Herman, D. Wiginton and J. Greenberg, Endothelial cell activation in a VEGF-A gradient, Relevance to cell fate decisions, Microvasc Res 80 (2010), 65-74.
2. M. Alikhani, Z. Alikhani, M. Raptis and D.T. Graves, TNF-alpha in vivo stimulates apoptosis in fibroblasts through aspase-8 activation and modulates the expression of pro-apoptotic genes, J Cell Physiol 201 (2004), 341-348. (Pubitemid 39453119)
3. Anonymous, Ethical guidelines for publication in clinical hemorheology and microcirculation, Clin Hemorheol Microcirc 44 (2010), 2.
4. E. Backe, R. Schwarting, J. Gerdes, M. Ernst and H. Stein, Ber-MAC3, new monoclonal antibody that defines human monocyte/macrophage differentiation antigen, J Clin Pathol 44 (1991), 936-945.
5. K.U. Belge, F. Dayyani, A. Horelt, M. Siedlar, M. Frankenberger, et al., The proinflammatory CD14+ CD16+ DR++ monocytes are a major source of TNF, J Immunol 168 (2002), 3536-3542. (Pubitemid 34250422)
6. M.A. Brown, C.S.Wallace, C.C. Anamelechi, E. Clermont,W.M. Reichert, et al., The use of mild trypsinization conditions in the detachment of endothelial cells to promote subsequent endothelialization on synthetic surfaces, Biomaterials 28 (2007), 3928-3935. (Pubitemid 47048362)
7. C. Buechler, M. Ritter, E. Orso, T. Langmann, J. Klucken, et al., Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli, J Leukoc Biol 67 (2000), 97-103. (Pubitemid 30046823)
8. L. Chi, Y. Li, L. Stehno-Bittel, J. Gao, D.C. Morrison, et al., Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha, J Interferon Cytokine Res 21 (2001), 231-240. (Pubitemid 32679511)
9. I. Cicha, K. Beronov, E.L. Ramirez, K. Osterode, M. Goppelt-Struebe, et al., Shear stress preconditioning modulates endothelial susceptibility to circulating TNF-[alpha] and monocytic cell recruitment in a simplified model of arterial bifurcations, Atherosclerosis 207 (2009), 93-102.
10. C.H. Coyle, S. Mendralla, S. Lanasa and K.N. Kader, Endothelial cell seeding onto various biomaterials causes superoxideinduced cell death, J Biomater Appl 22 (2007), 55-69. (Pubitemid 47082677)
11. V.A. Danis, M. Millington, V.J. Hyland and D. Grennan, Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism, Clin Exp Immunol 99 (1995), 303-310.
12. J.P. Edwards, X. Zhang, K.A. Frauwirth and D.M. Mosser, Biochemical and functional characterization of three activated macrophage populations, J Leukoc Biol 80 (2006), 1298-1307. (Pubitemid 44904968)
13. M. Frankenberger, T. Sternsdorf, H. Pechumer, A. Pforte and H.W. Ziegler-Heitbrock, Differential cytokine expression in human blood monocyte subpopulations, a polymerase chain reaction analysis, Blood 87 (1996), 373-377. (Pubitemid 26011852)
14. E. Grage-Griebenow, H.-D. Flad and M. Ernst, Heterogeneity of human peripheral blood monocyte subsets, J Leukocyte Biol 69 (2001), 11-20. (Pubitemid 32095112)
15. S. Hoepken, R. Fuhrmann, F. Jung and R.P. Franke, Shear resistance of human umbilical endothelial cells on different materials covered with or without extracellular matrix: Controlled in-vitro study, Clin Hemorheol Microcirc 43 (2009), 157-166.
16. F. Jung, C. Wischke and A. Lendlein, Degradable, multifunctional cardiovascular implants, challenges and hurdles, MRS Bulletin 35 (2010), 607-613.
17. G. Kaplanski,V. Marin, F. Montero-Julian, A. Mantovani and C. Farnarier, IL-6:Aregulator of the transition from neutrophil to monocyte recruitment during inflammation, Trends Immunol 24 (2003), 25-29. (Pubitemid 35462110)
18. L. Lanfrancone, D. Boraschi, P. Ghiara, B. Falini, F. Grignani, et al., Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL- 1], and IL-6) and are activated and stimulated to grow by IL-1, Blood 80 (1992), 2835-2842.
19. A. Mantovani, A. Sica, S. Sozzani, P. Allavena and A. Vecchi, et al., The chemokine system in diverse forms of macrophage activation and polarization, Trends Immunol 25 (2004), 677-686. (Pubitemid 39457982)
20. A. Mayer, S. Lee, F. Jung, G. Gruetz, A. Lendlein and B. Hiebl, CD14+ CD163+ IL-10+ monocytes/macrophages: Proangiogenic and non pro-inflammatory isolation, enrichment and long term secretion profile, Clin Hemorheol Microcirc 46 (2010), 217-223.
21. A. Mayer, K. Kratz, J. Cui, B. Hiebl, A. Lendlein and F. Jung, Interaction of angiogenically stimulated intermediate CD163+monocytes/ macrophages with soft hydrophobic poly(n-butyl acrylate) networks with elastic moduli matched to that of human arteries, Artif Organs (2011), in print.
22. A.-K. Olsson, A. Dimberg, J. Kreuger and L. Claesson-Welsh, VEGF receptor signalling? In control of vascular function, Nat Rev Mol Cell Biol 7 (2006), 359-371.
23. C. Patterson and M.S. Runge, Therapeutic myocardial angiogenesis via vascular endothelial growth factor gene therapy: Moving on down the road, Circulation 102 (2000), 940-942. (Pubitemid 30655999)
24. K. Pulford, K. Micklem, S. McCarthy, J. Cordell, M. Jones, et al., A monocyte/macrophage antigen recognized by the four antibodies GHI/61, Ber-MAC3, Ki-M8 and SM4, Immunology 75 (1992), 588-595.
25. V.P. Shastri and A. Lendlein, Materials in regenerative medicine, Adv Mater 21, (2009) 3231-3234.
26. V.P. Shastri and A. Lendlein, Eingineering materials for regenerative medicine, MRS Bull 35 (2010), 571-578.
27. J. Skrzeczyńska-Moncznik, M. Bzowska, S. Löseke, E. Grage-Griebenow, M. Zembala, et al., Peripheral blood CD14 high CD16+ monocytes are main producers of IL-10, Scand J Immunol 67 (2008), 152-159.
28. C. Sunderkotter, K. Steinbrink, M. Goebeler, R. Bhardwaj and C. Sorg, Macrophages and angiogenesis, J Leukoc Biol 55 (1994), 410-422. (Pubitemid 24097250)
29. K. Urschel, A. Worner, W.G. Daniel, C.D. Garlichs and I. Cicha, Role of shear stress patterns in the TNF-alpha-induced atherogenic protein expression and monocytic cell adhesion to endothelium, Clin Hemorheol Microcirc 46 (2010), 203-210.
30. H. Van Gorp, P.L. Delputte and H.J. Nauwynck, Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy, Mol Immunol 47 (2010), 1650-1660.
31. C.Watson, S. Whittaker, N. Smith, A.J. Vora, D.C. Dumonde, et al., IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes, Clin Exp Immunol 105 (1996), 112-119. (Pubitemid 26231833)
32. T.Weigel, G. Schinkel and A. Lendlein, Design and preparation of polymeric scaffolds for tissue engineering, Expert Rev Med Devices 3 (2006), 835-851. (Pubitemid 46017623)
33. N.K. Worrall, K. Chang, W.S. LeJeune, T.P. Misko, P.M. Sullivan, et al., TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms, Am J Physiol 273 (1997), 2565-2574.
34. L. Xue and H.P. Greisler, Angiogenic effect of fibroblast growth factor-1 and vascular endothelial growth factor and their synergism in a novel in vitro quantitative fibrin-based 3-dimensional angiogenesis system, Surgery 132 (2002), 259-267. (Pubitemid 35024771)
35. L. Ziegler-Heitbrock, P. Ancuta, S. Crowe, M. Dalod, V. Grau, et al. Nomenclature of monocytes and dendritic cells in blood, Blood 116 (2010), e74-e80.